# South America Metabolomics Services Market

> South America Metabolomics Services Market Research Report By Product Type (Chromatography, Metabolomics Bioinformatics Services, Mass Spectrometry), By Application (Biomedical and Pharmaceutical, Agriculture, Food), and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.73%
- **2024:** $ 32.15 Million
- **2025:** $ 34.63 Million
- **2035:** $ 72.94 Million
- **Key Players:** Metabolon Inc (US), Biocrates Life Sciences AG (AT), Agilent Technologies Inc (US), Thermo Fisher Scientific Inc (US), Waters Corporation (US), PerkinElmer Inc (US), Sierra Analytics Inc (US), Creative Proteomics (US)

**Report ID:** MRFR/HC/47908-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-america-metabolomics-services-market-49662

---

## Market Summary

## **South America Metabolomics Services Market Overview**

As per MRFR analysis, the South America Metabolomics Services Market Size was estimated at 131 (USD Million) in 2023. The South America Metabolomics Services Market Industry is expected to grow from 147(USD Million) in 2024 to 524.44 (USD Million) by 2035. The South America Metabolomics Services Market CAGR (growth rate) is expected to be around 12.258% during the forecast period (2025 - 2035)

**Key South America Metabolomics Services Market Trends Highlighted**

The South America Metabolomics Services Market is witnessing significant growth driven by an increasing emphasis on personalized medicine and advancements in technology. Researchers and healthcare professionals in the region are focusing on how metabolomics can improve drug discovery and development processes. This evolving field is also supported by various governments in South America, which are investing in biotechnology and related research to enhance healthcare solutions. 

The integration of metabolomics into clinical practices showcases the vital link between metabolic profiles and health conditions, creating a demand for comprehensive metabolomic analyses.Moreover, opportunities are being explored in collaboration between academia and industry. South American universities and research institutions are forming partnerships with clinical laboratories and biotechnology companies to accelerate metabolomics research. This collaboration aims to harness local biodiversity for bioprospecting, capitalizing on native plant species that may offer unique metabolic profiles beneficial for drug development. 

The ongoing digital transformation in healthcare, including the adoption of artificial intelligence and data analytics, presents additional opportunities in metabolomics by streamlining data interpretation and improving the accuracy of results.In recent times, there has been a noticeable trend toward expanding metabolomics applications beyond traditional sectors into areas like agriculture, food safety, and environmental monitoring. 

This diversification reflects a growing recognition of the role metabolites play in various biological and ecological contexts. As South America continues to enhance its research capabilities and infrastructure in metabolomics, these trends signal a robust future for the region's market, aligning with global developments in the biomolecular landscape.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South America Metabolomics Services Market Drivers**

**Increasing Chronic Disease Incidence**

One major factor propelling the South America Metabolomics Services Market is the increasing incidence of chronic illnesses, particularly metabolic disorders. According to Pan American Health Organization research, diabetes rates have increased by 20% in the past ten years, and chronic illnesses are responsible for more than 60% of fatalities in South America. Metabolomics is a crucial component of the sophisticated diagnosis and treatment strategies required by this growing health catastrophe. 

The need for metabolomic services in the area is fueled by well-known organizations that stress the value of metabolic profiles in better understanding these conditions, such as the Brazilian Society of Endocrinology and Metabology.

**Rising Focus on Personalized Medicine**

The shift towards personalized medicine is significantly influencing the growth of the South America Metabolomics Services Market industry. Recent studies indicate that personalized treatments can improve patient outcomes by up to 30%. The Brazilian Ministry of Health has initiated programs supporting personalized medicine, highlighting its potential and expanding funding for metabolomics research. 

Major pharmaceutical companies are increasingly investing in this field, recognizing the potential to tailor therapies based on individual metabolic profiles.This trend is likely to boost the demand for metabolomic services across South America as healthcare professionals seek advanced techniques to enhance patient care.

**Advancements in Research and Development**

Continuous advancements in Research and Development (R&D) for analytical technologies drive the South America Metabolomics Services Market industry forward. With the Brazilian state of So Paulo hosting 42% of the country's research institutions, significant investments in R&D have been made, including over 200 million USD dedicated to biotechnology and metabolomics research in the last five years. 

These developments result in more sophisticated and accurate metabolomic analyses, creating a robust market for related services.This trend has inspired universities and healthcare facilities to establish research partnerships that will catalyze further growth in metabolomic capabilities, beneficially impacting health outcomes.

**South America Metabolomics Services Market Segment Insights**

**Metabolomics Services Market Product Type Insights**

The South America Metabolomics Services Market is characterized by its diverse range of Product Types, primarily including Chromatography, Metabolomics Bioinformatics Services, and Mass Spectrometry. Each of these services plays a crucial role in the overall landscape of metabolomics, catering to various research needs in fields such as pharmaceuticals, agriculture, and environmental science. 

Chromatography is fundamental in separating complex biological samples, thereby allowing for detailed analysis of metabolites. This technique is favored for its effectiveness and precision, contributing significantly to research and quality control in numerous industries.Metabolomics Bioinformatics Services have emerged as indispensable due to the growing volume of data generated from metabolomic studies. With the increasing complexity of biological systems, the integration of bioinformatics tools is essential for data interpretation and for revealing insights that might otherwise remain hidden. 

As such, these services complement traditional techniques by providing analytical frameworks that help researchers make sense of their findings and drive innovations in drug development or personalized medicine.Mass Spectrometry is another key component of the South America Metabolomics Services Market, known for its sensitivity and accuracy in detecting and quantifying metabolites. This technology is widely embraced for its applications in clinical diagnostics and biomarker discovery, helping researchers identify significant metabolomic changes associated with various diseases. 

The significant impact of these Product Types on the South America Metabolomics Services Market denotes a robust growth potential driven by scientific advancements and increasing demand for personalized healthcare solutions. With the expanding collaboration between academic institutions and industry players, coupled with governmental support for biotechnological research, the regional metabolomics landscape is poised for continued evolution, highlighting the importance of these services in advancing our understanding of metabolic processes across diverse applications.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Metabolomics Services Market Application Insights**

The South America Metabolomics Services Market demonstrates robust growth across diverse applications, with significant contributions from the Biomedical and Pharmaceutical, Agriculture, and Food sectors. The Biomedical and Pharmaceutical application plays a crucial role as it aids in drug development, personalized medicine, and understanding metabolic diseases, enhancing research and clinical outcomes. 

In agriculture, metabolomics is gaining traction as it helps in optimizing crop yields and developing sustainable practices, positively impacting food security in the region.Additionally, the Food industry benefits from metabolomics by analyzing nutritional content and food safety, ensuring high quality and compliance with regulatory standards. Trends in sustainability and health consciousness among consumers are driving demand, creating opportunities for innovation in service offerings. However, challenges such as data standardization and high operational costs remain prevalent in these applications. 

The South America Metabolomics Services Market is well-positioned to address these challenges and leverage growth drivers, reflecting the importance of these sectors in the region's economy and public health landscape.Overall, the market is witnessing a paradigm shift towards integrating metabolomics into various applications, establishing its significance in scientific research and commercial sectors across South America.

**South America Metabolomics Services Market Key Players and Competitive Insights**

The South America Metabolomics Services Market has seen significant growth and evolution, reflecting broader trends in biotechnology and healthcare. As an integral part of personalized medicine, metabolomics services are critical for understanding metabolic processes, enabling researchers and healthcare professionals to develop more targeted therapies and diagnostic tools. This sector is characterized by a variety of service providers offering comprehensive solutions that range from data analysis and bioinformatics to sample preparation and analysis. The competitive landscape is marked by a mix of well-established companies and emerging players, each leveraging technological advancements to enhance their service offerings. 

The market dynamics are influenced by increasing research funding, a growing awareness of the importance of metabolic profiling, and the demand for innovative solutions to address complex health issues in the region. ChromaDex has established a formidable presence in the South America Metabolomics Services Market through its commitment to providing high-quality analytical services and innovative metabolomic products. The company is well-regarded for its strong research capabilities and operates state-of-the-art laboratories that enable comprehensive metabolomic analyses. ChromaDex’s strengths lie in its advanced technologies that facilitate accurate and reproducible results, catering specifically to the unique needs of South American clients. 

The company's focus on building strategic partnerships with local research institutions and academic organizations has enhanced its market penetration, enabling it to offer tailored solutions that meet the specific needs of the South American scientific community. This localized approach has positioned ChromaDex as a trusted partner in various research initiatives across the region.Biocrates Life Sciences has also carved a niche in the South America Metabolomics Services Market, offering a range of targeted metabolomics products and services. 

The company specializes in high-throughput analysis of metabolites, providing essential tools for researchers in nutritional science, clinical research, and drug development. Biocrates' strengths include a robust platform for precise and reliable metabolomic profiling, which is crucial for advancing research in the region. The company actively engages in partnerships and collaborations with local universities and research institutions, contributing to its strong market presence. 

Furthermore, Biocrates Life Sciences often seeks to expand its reach through strategic mergers and acquisitions, ensuring a comprehensive service offering for its clients. As the demand for metabolomics services continues to grow, Biocrates remains dedicated to delivering cutting-edge solutions tailored to the specific requirements of the South American market, thereby reinforcing its competitive edge in this fast-evolving sector.

**Key Companies in the South America Metabolomics Services Market Include**

**South America Metabolomics Services Market Industry Developments**

In recent months, the South America Metabolomics Services Market has seen significant developments, particularly as companies like Thermo Fisher Scientific and Agilent Technologies continue to expand their service capacities in the region. The Brazilian market, in particular, is witnessing a surge in demand for metabolomics services due to increased research activities and a growing emphasis on personalized medicine. In April 2023, PerkinElmer announced its strategic partnership with local laboratories in Brazil to enhance its metabolomics offerings, aiming to better serve the healthcare and biopharmaceutical sectors. 

Mergers and acquisitions have been limited, but notable movements include Phenomenex's acquisition of a smaller local player in March 2023, allowing it to broaden its service portfolio. The market is also reflecting growth valuations; for instance, SCIEX reported a revenue increase of 15% in their South American operations in Q2 2023, highlighting the region's potential. Historical developments over the last two to three years, such as the increase in government funding for metabolomics research in Argentina, have significantly impacted market dynamics. 

As a result, companies are positioning themselves strategically to capitalize on the region's growth prospects, aligning their innovations with local demand across various sectors, including agriculture and healthcare.

**South America Metabolomics Services Market Segmentation Insights**

## Market Drivers

### Expansion of Research Institutions

The proliferation of research institutions across South America is significantly influencing the metabolomics services market. Universities and research centers are increasingly focusing on metabolomics to explore various biological processes and disease mechanisms. This expansion is supported by government initiatives aimed at enhancing scientific research capabilities. In 2025, it is estimated that research funding in South America will exceed $10 billion, with a substantial portion directed towards metabolomics studies. This influx of funding is likely to foster collaborations between academic institutions and metabolomics service providers, thereby driving innovation and application in the field. The growth of research institutions is expected to create a robust demand for metabolomics services, facilitating advancements in health and disease research.

### Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases in South America is a pivotal driver for the metabolomics services market. Conditions such as diabetes, cardiovascular diseases, and cancer are becoming more prevalent, necessitating advanced diagnostic and therapeutic approaches. Metabolomics services provide critical insights into disease mechanisms, enabling personalized treatment strategies. The market is projected to grow as healthcare providers seek to implement metabolomics in clinical settings. In 2025, the market for chronic disease management in South America is expected to reach approximately $15 billion, with a significant portion allocated to metabolomics services. This trend indicates a growing recognition of the importance of metabolic profiling in understanding disease progression and treatment efficacy.

### Technological Integration in Healthcare

The integration of advanced technologies in healthcare drives the metabolomics services market. Innovations such as artificial intelligence, machine learning, and high-throughput screening are enhancing the capabilities of metabolomics analyses. These technologies enable more efficient data processing and interpretation, leading to faster and more accurate results. In South America, healthcare providers are increasingly adopting these technologies to improve diagnostic accuracy and patient outcomes. The market for healthcare technology in the region is expected to grow by 25% annually, with metabolomics services playing a crucial role in this transformation. This technological evolution is likely to create new opportunities for service providers, fostering growth in the metabolomics services market.

### Government Initiatives Supporting Biotechnology

Government initiatives aimed at promoting biotechnology research and development are significantly impacting the metabolomics services market in South America. Various countries in the region are implementing policies to support innovation in life sciences, including metabolomics. These initiatives often include funding programs, tax incentives, and infrastructure development to foster a conducive environment for research. In 2025, government investment in biotechnology is projected to reach $5 billion, with a notable portion allocated to metabolomics research. This support is likely to enhance collaboration between public and private sectors, driving advancements in metabolomics services. As a result, the market is expected to experience substantial growth, reflecting the increasing importance of metabolomics in addressing health challenges.

### Increased Awareness of Nutritional Metabolomics

There is a growing awareness of the role of nutrition in health, which is driving interest in nutritional metabolomics within South America. As consumers become more health-conscious, the demand for personalized nutrition solutions is rising. Metabolomics services can analyze metabolic responses to dietary changes, providing valuable insights for tailored nutrition plans. This trend is likely to expand the market as food and beverage companies seek to develop products that cater to specific metabolic profiles. In 2025, the nutritional metabolomics segment is projected to account for approximately 20% of the overall metabolomics services market in South America, reflecting the increasing integration of metabolomics in dietary research and product development.

## Future Outlook

The [Metabolomics Services Market](https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435) is projected to grow at a 7.73% CAGR from 2025 to 2035, driven by advancements in technology, increasing research funding, and rising demand for personalized medicine.

**New opportunities:**

- Development of integrated metabolomics platforms for clinical diagnostics.
- Expansion of metabolomics services into agricultural biotechnology applications.
- Partnerships with pharmaceutical companies for drug discovery and development.

By 2035, the metabolomics services market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product and Service: Chromatography (Largest) vs. Mass Spectrometry (Fastest-Growing)

In the South America metabolomics services market, Chromatography holds the largest share, driven by its extensive application in various fields, including pharmaceuticals and environmental testing. This segment's dominance is attributed to its reliability and efficiency in the separation and analysis of complex mixtures, making it an essential tool for metabolomics research.

On the other hand, Mass Spectrometry is emerging as the fastest-growing segment due to its advanced capabilities in identifying and quantifying metabolites with high sensitivity and specificity. The increasing demand for personalized medicine and proactive healthcare solutions is propelling investments in this technology, leading to significant growth in its adoption within metabolomics services.

Chromatography (Dominant) vs. Mass Spectrometry (Emerging)

Chromatography is a dominant force in the South America metabolomics services market, noted for its versatility and robustness in various applications. Its well-established methods enable precise separation of metabolic compounds, which is crucial in monitoring biochemical processes. Conversely, Mass Spectrometry, while emerging, is rapidly gaining traction as a vital analytical technique due to its unparalleled accuracy in metabolite identification. The convergence of these two segments reflects the market's innovative edge, where chromatography underpins traditional methods and mass spectrometry supplements with cutting-edge analysis capabilities.

### By Application: Biomedical and Pharmaceutical (Largest) vs. Food (Fastest-Growing)

In the South America metabolomics services market, the application segment is marked by a diverse array of values, with 'Biomedical and Pharmaceutical' commanding the largest share due to the burgeoning demand for personalized medicine and targeted therapies. This segment’s significant market presence is driven by the increasing investment in biopharmaceutical R&D and the need for advanced diagnostics technologies which enhance patient care.

Conversely, the 'Food' sector is gaining traction and is recognized as the fastest-growing segment. Driven by the rise in food safety concerns, quality control, and nutritional assessment, this segment is experiencing rapid adoption of metabolomics techniques. The need for innovative food products and sustainable agriculture practices further fuels this growth, reflecting a broader trend towards health-conscious consumer behavior and regulatory compliance.

Biomedical and Pharmaceutical: Dominant vs. Food: Emerging

The 'Biomedical and Pharmaceutical' segment is characterized by its robust application in drug development and disease diagnosis, positioning it as the dominant force within the market. Key players in this sector are heavily focused on integrating metabolomics into their research initiatives, thereby enhancing drug efficacy and safety profiles. The segment benefits from collaboration with academic institutions and research centers that foster innovation. In contrast, the 'Food' segment, while emerging, showcases significant potential as it responds to consumer demand for transparency and quality assurance in food products. The application of metabolomics in food safety, quality enhancement, and shelf-life extension is becoming essential for manufacturers seeking to stay competitive in a rapidly evolving market.

## Regional Market Share Analysis

### Brazil : Strong Growth Driven by Innovation

Brazil holds a dominant market share of 15.5% in the South American metabolomics services sector, valued at approximately $200 million. Key growth drivers include increasing investments in biotechnology and healthcare, alongside a rising demand for personalized medicine. Regulatory support from the Brazilian Health Regulatory Agency (ANVISA) and government initiatives to promote research and development are also pivotal. The country's robust infrastructure and industrial development further facilitate market expansion.

### Mexico : Growing Demand and Investment Opportunities

Mexico accounts for a 5.0% market share in the metabolomics services market, valued at around $60 million. The growth is driven by increasing healthcare investments and a focus on chronic disease management. Demand for metabolomics is rising in academic research and pharmaceutical sectors, supported by government initiatives to enhance healthcare infrastructure. Regulatory frameworks are evolving to accommodate new technologies, fostering a favorable business environment.

### Argentina : Focus on Research and Development

With a market share of 7.0%, Argentina's metabolomics services market is valued at approximately $80 million. The sector is experiencing growth due to increased funding for research and development in life sciences. Demand is particularly strong in agricultural and clinical research applications. Government policies aimed at promoting scientific innovation and collaboration with international organizations are enhancing the market landscape, supported by a growing number of research institutions.

### Rest of South America : Varied Market Dynamics Across Regions

The Rest of South America holds a market share of 4.65%, valued at about $50 million. This sub-region showcases diverse market dynamics, with varying levels of investment in metabolomics services. Countries like Chile and Colombia are emerging as key players, driven by increasing healthcare needs and research initiatives. The competitive landscape includes both local and international players, with a focus on agricultural and environmental applications, supported by regional collaborations and partnerships.

## Competitive Benchmarking

The metabolomics services market in South America is characterized by a dynamic competitive landscape, driven by increasing demand for personalized medicine, advancements in analytical technologies, and a growing emphasis on research and development in the life sciences sector. Key players such as Metabolon Inc (US), Biocrates Life Sciences AG (AT), and Agilent Technologies Inc (US) are strategically positioned to leverage these trends. Metabolon Inc (US) focuses on innovation in metabolomic profiling, enhancing its service offerings through advanced data analytics and integration with clinical research. Biocrates Life Sciences AG (AT) emphasizes partnerships with academic institutions to foster research collaborations, thereby expanding its market reach and enhancing its product portfolio. Agilent Technologies Inc (US) is investing in digital transformation initiatives, aiming to streamline operations and improve customer engagement through advanced data management solutions. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and collaborative growth.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce costs. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure allows for a diverse range of services and innovations, fostering a healthy environment for growth and development.

In October  Metabolon Inc (US) announced a strategic partnership with a leading South American university to develop a comprehensive metabolomics database aimed at advancing research in chronic diseases. This collaboration is expected to enhance Metabolon's capabilities in data analytics and expand its influence in the academic sector, potentially leading to new service offerings tailored to regional health challenges. The strategic importance of this partnership lies in its potential to position Metabolon as a leader in the integration of metabolomics with clinical research in South America.

In September  Biocrates Life Sciences AG (AT) launched a new suite of targeted metabolomics kits designed specifically for the South American market, addressing local health concerns such as metabolic disorders. This product launch not only demonstrates Biocrates' commitment to regional needs but also enhances its competitive edge by providing tailored solutions. The strategic significance of this move is underscored by the growing demand for personalized healthcare solutions in the region, which could lead to increased market penetration and customer loyalty.

In August  Agilent Technologies Inc (US) expanded its service offerings by acquiring a local metabolomics service provider in Brazil. This acquisition is likely to enhance Agilent's operational capabilities and market presence in South America, allowing for more localized service delivery and improved customer support. The strategic importance of this acquisition lies in Agilent's ability to leverage local expertise and resources, thereby strengthening its competitive position in a rapidly evolving market.

As of November  current trends in the metabolomics services market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in analytical processes. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on technological advancements and supply chain reliability rather than solely on price. This shift suggests that companies that prioritize innovation and customer-centric solutions will likely emerge as leaders in the metabolomics services market.

## Recent News & Developments

In recent months, the South America Metabolomics Services Market has seen significant developments, particularly as companies like Thermo Fisher Scientific and Agilent Technologies continue to expand their service capacities in the region. The Brazilian market, in particular, is witnessing a surge in demand for metabolomics services due to increased research activities and a growing emphasis on personalized medicine. In April 2023, PerkinElmer announced its strategic partnership with local laboratories in Brazil to enhance its metabolomics offerings, aiming to better serve the healthcare and biopharmaceutical sectors. 

Mergers and acquisitions have been limited, but notable movements include Phenomenex's acquisition of a smaller local player in March 2023, allowing it to broaden its service portfolio. The market is also reflecting growth valuations; for instance, SCIEX reported a revenue increase of 15% in their South American operations in Q2 2023, highlighting the region's potential. Historical developments over the last two to three years, such as the increase in government funding for metabolomics research in Argentina, have significantly impacted market dynamics. 

As a result, companies are positioning themselves strategically to capitalize on the region's growth prospects, aligning their innovations with local demand across various sectors, including agriculture and healthcare.

## Report Scope

| MARKET SIZE 2024 | 32.15(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 34.63(USD Million) |
| MARKET SIZE 2035 | 72.94(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.73% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Metabolon Inc (US), Biocrates Life Sciences AG (AT), Agilent Technologies Inc (US), Thermo Fisher Scientific Inc (US), Waters Corporation (US), PerkinElmer Inc (US), Sierra Analytics Inc (US), Creative Proteomics (US) |
| Segments Covered | Product and Service, Application |
| Key Market Opportunities | Emerging technologies in metabolomics services market enhance personalized medicine and agricultural applications. |
| Key Market Dynamics | Rising demand for personalized medicine drives growth in metabolomics services across South America. |
| Countries Covered | Brazil, Mexico, Argentina, Rest of South America |

## Frequently Asked Questions

**Q: What was the overall market valuation for metabolomics services in 2024?**
A: The overall market valuation for metabolomics services was $32.15 Million in 2024.

**Q: What is the projected market valuation for metabolomics services by 2035?**
A: The projected market valuation for metabolomics services is $72.94 Million by 2035.

**Q: What is the expected CAGR for the metabolomics services market during the forecast period 2025 - 2035?**
A: The expected CAGR for the metabolomics services market during the forecast period 2025 - 2035 is 7.73%.

**Q: Which companies are considered key players in the metabolomics services market?**
A: Key players in the metabolomics services market include Metabolon Inc, Biocrates Life Sciences AG, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc, Sierra Analytics Inc, and Creative Proteomics.

**Q: What were the revenue figures for chromatography services in 2024?**
A: In 2024, the revenue for chromatography services was between $10.0 Million and $23.0 Million.

**Q: How much did metabolomics bioinformatics services generate in 2024?**
A: Metabolomics bioinformatics services generated between $12.0 Million and $28.0 Million in 2024.

**Q: What was the revenue range for mass spectrometry services in 2024?**
A: The revenue range for mass spectrometry services in 2024 was between $10.15 Million and $21.94 Million.

**Q: Which applications are driving growth in the metabolomics services market?**
A: The applications driving growth include biomedical and pharmaceutical, agriculture, and food sectors.

**Q: What were the revenue figures for the biomedical and pharmaceutical application in 2024?**
A: The biomedical and pharmaceutical application generated between $12.86 Million and $30.0 Million in 2024.

**Q: What is the projected growth for the agriculture application in the metabolomics services market?**
A: The agriculture application is projected to generate between $10.0 Million and $20.0 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-america-metabolomics-services-market-49662*